Published in Am J Public Health on October 01, 2001
Not just a drop in the bucket: expanding access to point-of-use water treatment systems. Am J Public Health (2001) 2.14
High adherence is necessary to realize health gains from water quality interventions. PLoS One (2012) 1.60
The CARE-CDC health initiative: a model for global participatory research. Am J Public Health (2001) 1.38
Diarrhoea prevention in a high-risk rural Kenyan population through point-of-use chlorination, safe water storage, sanitation, and rainwater harvesting. Epidemiol Infect (2008) 1.31
Water, sanitation, hygiene and enteric infections in children. Arch Dis Child (2013) 1.13
To promote adoption of household health technologies, think beyond health. Am J Public Health (2013) 1.03
Evidence on the Effectiveness of Water, Sanitation, and Hygiene (WASH) Interventions on Health Outcomes in Humanitarian Crises: A Systematic Review. PLoS One (2015) 0.75
Theory-driven behavioral intervention research for the control of diarrheal diseases. Soc Sci Med (1992) 2.88
Membrane filtration differentiation of E. coli from coliforms in the examination of water. J Appl Bacteriol (1989) 2.24
DNA diagnostics--molecular techniques and automation. Science (1988) 8.85
A ligase-mediated gene detection technique. Science (1988) 7.61
Public-health impact of outdoor and traffic-related air pollution: a European assessment. Lancet (2000) 6.95
Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation (1998) 2.90
Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay. Proc Natl Acad Sci U S A (1990) 2.88
European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis (2011) 2.47
Tick-borne diseases in the United States. N Engl J Med (1993) 2.39
Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect (2011) 2.23
Assessment of deaths attributable to air pollution: should we use risk estimates based on time series or on cohort studies? Am J Epidemiol (2001) 2.19
Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication. Antimicrob Agents Chemother (1995) 2.04
Development and clinical significance of the musculus dorsoepitrochlearis in men. Clin Anat (2009) 1.98
Challenges in implementing a point-of-use water quality intervention in rural Kenya. Am J Public Health (2001) 1.91
T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia. Hepatology (1996) 1.88
Are there national risk factors for epidemic cholera? The correlation between socioeconomic and demographic indices and cholera incidence in Latin America. Int J Epidemiol (1998) 1.86
Epidemic intelligence: a new framework for strengthening disease surveillance in Europe. Euro Surveill (2006) 1.75
Increased frequency of the HLA-DR15 (B1*15011) allele in German patients with self-limited hepatitis C virus infection. Eur J Clin Invest (1999) 1.68
Seeking safe storage: a comparison of drinking water quality in clay and plastic vessels. Am J Public Health (2001) 1.66
Mitochondrial aldehyde dehydrogenase from human liver. Primary structure, differences in relation to the cytosolic enzyme, and functional correlations. Eur J Biochem (1985) 1.65
Epidemic cholera in the new world: translating field epidemiology into new prevention strategies. Emerg Infect Dis (1996) 1.63
Identification of clusters of biallelic polymorphic sequence-tagged sites (pSTSs) that generate highly informative and automatable markers for genetic linkage mapping. Genomics (1992) 1.55
Collaboration, cholera, and cyclones: a project to improve point-of-use water quality in Madagascar. Am J Public Health (2001) 1.52
Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int (1999) 1.51
Release of chemosterilized males for the control of Anopheles albimanus in El Salvador. 3. Field methods and population control. Am J Trop Med Hyg (1974) 1.48
Parvovirus B19 DNA is frequently present in recombinant coagulation factor VIII products. Thromb Haemost (1996) 1.46
Roles of DnaK and RpoS in starvation-induced thermotolerance of Escherichia coli. J Bacteriol (1998) 1.42
Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs. Thromb Haemost (1994) 1.40
[Influencing of mitosis rate in endometrial carcinomas using 17-hydroxynorprogesterone capronate in women]. Arch Gynakol (1972) 1.38
Diarrhoea prevention in a high-risk rural Kenyan population through point-of-use chlorination, safe water storage, sanitation, and rainwater harvesting. Epidemiol Infect (2008) 1.31
Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study). HIV Med (2010) 1.24
Identification of the phosphorylation site for cAMP-dependent protein kinase on Na+,K(+)-ATPase and effects of site-directed mutagenesis. J Biol Chem (1994) 1.21
Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C. J Hepatol (1999) 1.20
Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19. Pharmacogenomics J (2005) 1.19
Comparison of three classes of human liver alcohol dehydrogenase. Emphasis on different substrate binding pockets. Eur J Biochem (1990) 1.19
CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine. J Clin Pharm Ther (2006) 1.16
A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer. Ann Oncol (2011) 1.15
Epidemic cholera in urban Zambia: hand soap and dried fish as protective factors. Epidemiol Infect (2006) 1.14
Purification, characterization and HPLC assay of Salmonella glucose-1-phosphate thymidylyl-transferase from the cloned rfbA gene. Eur J Biochem (1993) 1.14
Cochlear function after selective inner hair cell degeneration induced by carboplatin. Hear Res (1994) 1.12
Adoption of safe water behaviors in Zambia: comparing educational and motivational approaches. Educ Health (Abingdon) (2000) 1.12
Ligand requirements of the human corticotropin-releasing factor-binding protein. Endocrinology (1995) 1.11
Genotypic coreceptor analysis. Eur J Med Res (2007) 1.10
Blood donors in Kenya: a comparison of voluntary and family replacement donors based on a population-based survey. Vox Sang (2010) 1.10
The role of health care in the spread of HIV/AIDS in Africa: evidence from Kenya. Int J STD AIDS (2009) 1.08
CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes. J Immunol (1997) 1.08
HLA-DQ6 and ingestion of contaminated water: possible gene-environment interaction in an outbreak of Leptospirosis. Genes Immun (2004) 1.07
Maraviroc in treatment-experienced patients with HIV-1 infection - experience from routine clinical practice. Eur J Med Res (2010) 1.06
Preliminary results on the action of cosmic heavy ions on the development of eggs of Artemia salina. Life Sci Space Res (1974) 1.05
Cultivation and phylogenetic characterization of a newly recognized human pathogenic protozoan. J Infect Dis (1994) 1.05
Heat-related mortality in selected United States cities, summer 1999. Am J Forensic Med Pathol (2001) 1.04
Comparison between a nucleic acid sequence-based amplification and branched DNA test for quantifying HIV RNA load in blood plasma. J Virol Methods (2000) 1.03
Epidemic cholera in the Amazon: the role of produce in disease risk and prevention. J Infect Dis (1994) 1.02
Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: a randomized, controlled pilot study. Eur J Clin Invest (1998) 1.02
Catalytic mechanism of serine proteases: reexamination of the pH dependence of the histidyl 1J13C2-H coupling constant in the catalytic triad of alpha-lytic protease. Proc Natl Acad Sci U S A (1981) 1.01
Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT(3) antagonists tropisetron and ondansetron. Pharmacogenomics J (2010) 1.01
Release of chemosterilized males for the control of Anopheles albimanus in El Salvador. IV. Dynamics of the test population. Am J Trop Med Hyg (1974) 1.01
Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours. Curr Oncol (2012) 1.00
Carboplatin ototoxicity: an animal model. J Laryngol Otol (1993) 0.98
The failure to separate human X-and Y-spermatozoa by the millipore filtration technique. J Reprod Med (1978) 0.98
Rapid detection and quantitation of precipitating streptokinase-antibodies. Thromb Diath Haemorrh (1974) 0.97
[Indications for appendectomy from the ultrasound-clinical viewpoint]. Zentralbl Chir (1998) 0.97
The Biostack experiment on Apollo 16. Life Sci Space Res (1973) 0.95
Variation analysis of six HCV viral load assays using low viremic HCV samples in the range of the clinical decision points for HCV protease inhibitors. Med Microbiol Immunol (2014) 0.95
Left ventricular volumes by gated equilibrium radionuclide angiography: a new method. Circulation (1979) 0.94
Structure of uncomplexed and linoleate-bound Candida cylindracea cholesterol esterase. Structure (1995) 0.94
Human liver alcohol dehydrogenase. 1. The primary structure of the beta 1 beta 1 isoenzyme. Eur J Biochem (1984) 0.94
A novel form of the polypeptide PHI isolated in high yield from bovine upper intestine. Relationships to other peptides of the glucagon-secretin family. Eur J Biochem (1984) 0.92
Two severe cases of tick-borne encephalitis despite complete active vaccination--the significance of neutralizing antibodies. J Neurol (2004) 0.91
Selective inner hair cell ototoxicity induced by carboplatin. Laryngoscope (1994) 0.91
Hanle effect in coherent backscattering. Phys Rev Lett (2002) 0.91
Plasticity of tonotopic maps in auditory midbrain following partial cochlear damage in the developing chinchilla. Exp Brain Res (1998) 0.91
Human liver alcohol dehydrogenase. 2. The primary structure of the gamma 1 protein chain. Eur J Biochem (1984) 0.90
Bringing safe water to remote populations: an evaluation of a portable point-of-use intervention in rural Madagascar. Am J Public Health (2007) 0.90
cDNA and protein structure for the alpha subunit of human liver alcohol dehydrogenase. Biochemistry (1986) 0.89
Cholera prevention with traditional and novel water treatment methods: an outbreak investigation in Fort-Dauphin, Madagascar. Am J Public Health (2001) 0.89
Networking for applied field epidemiology - Eastern Mediterranean Public Health Network (EMPHNET) Conference 2011. East Mediterr Health J (2011) 0.88
Neonatal cochlear hearing loss results in developmental abnormalities of the central auditory pathways. Acta Otolaryngol (1993) 0.88
[Hormonal pattern in premenopauseal cycles (author's transl)]. Arch Gynakol (1977) 0.88
Rotavirus from children of an urban settlement of Papua New Guinea. J Trop Pediatr (1990) 0.88
[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005]. Dtsch Med Wochenschr (2007) 0.88
Human liver mitochondrial aldehyde dehydrogenase: a C-terminal segment positions and defines the structure corresponding to the one reported to differ in the Oriental enzyme variant. FEBS Lett (1984) 0.88
Floral biology and reproductive isolation by floral scent in three sympatric aroid species in French Guiana. Plant Biol (Stuttg) (2010) 0.88
Reversible ALS-like disorder in HIV infection. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology (2002) 0.87
Steady-state dependence of stress on cross-bridge phosphorylation in the swine carotid media. Am J Physiol (1992) 0.87
Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patients. Br J Cancer (2011) 0.87
The genetic diversification of the HIV type 1 gag p17 gene in patients infected from a common source. AIDS Res Hum Retroviruses (1995) 0.87
Limitations of recently published review of national influenza pandemic plans in Europe. Euro Surveill (2006) 0.87
[Biological hallucinogens. New patterns of substance abuse in young addicts?]. Nervenarzt (1999) 0.86
Chronopharmacokinetics and cardiovascular effects of nifedipine. Chronobiol Int (1991) 0.86
Diagnosis of acute and latent varicella-zoster virus infections using the polymerase chain reaction. J Med Virol (1991) 0.86
Separation and characterization of isoforms of DT-diaphorase from rat liver cytosol. Biochim Biophys Acta (1992) 0.86
Structural relationships among class I isozymes of human liver alcohol dehydrogenase. Biochemistry (1985) 0.86
[Endocrine protective mechanisms against endometrial and breast cancer]. Dtsch Med Wochenschr (1969) 0.85
Enzyme linked immunosorbent assay using recombinant HuD-autoantigen for serodiagnosis of paraneoplastic neurological syndromes. Acta Neurol Scand (2001) 0.85
Coherence and polarization of light propagating through scattering media and biological tissues. Appl Opt (1998) 0.85
Purification, characterization, and high performance liquid chromatography assay of Salmonella glucose-1-phosphate cytidylyltransferase from the cloned rfbF gene. J Biol Chem (1994) 0.85
Structure of rabbit liver fructose 1,6-bisphosphatase at 2.3 A resolution. Acta Crystallogr D Biol Crystallogr (1999) 0.84
Role of HIV-1 phenotype in viral pathogenesis and its relation to viral load and CD4+ T-cell count. J Med Virol (1998) 0.83
De novo expression of the alpha5beta1-fibronectin receptor in HT29 colon-cancer cells reduces activity of C-SRC. Increase of C-SRC activity by attachment on fibronectin. Int J Cancer (1998) 0.83